Skip to content

Clinical trials

Phase 2 Rectal Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 2 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20061
20072
20092
20101
20121
20131
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Royal Marsden NHS Foundation Trust3
Cardiff University2
Sanofi2
Cheryl Pugh1
Delcath Systems Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Genzyme, a Sanofi Company1
GlaxoSmithKline1
Mast Therapeutics, Inc.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms15
Colorectal Neoplasms10
Colonic Neoplasms7
Neoplasm Metastasis2
Adenocarcinoma1
Adenocarcinoma, Mucinous1
Carcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Gastrointestinal Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.